These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11552687

  • 1. Interaction of new PNA-based molecules with TAR RNA of HIV-1: molecular modelling and biological evaluation.
    Terreux R, Pairot S, Cabrol-Bass D, Patino N, Condom R.
    J Mol Graph Model; 2001; 19(6):579-85, 614-5. PubMed ID: 11552687
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T, Kaushik N, Pandey PK, Kashanchi F, Deng L, Pandey VN.
    Biochemistry; 2000 Sep 26; 39(38):11532-9. PubMed ID: 10995220
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
    Kaushik N, Basu A, Pandey VN.
    Antiviral Res; 2002 Oct 26; 56(1):13-27. PubMed ID: 12323396
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).
    Zhao H, Li J, Jiang L.
    Biochem Biophys Res Commun; 2004 Jul 16; 320(1):95-9. PubMed ID: 15207707
    [Abstract] [Full Text] [Related]

  • 5. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.
    Filikov AV, Mohan V, Vickers TA, Griffey RH, Cook PD, Abagyan RA, James TL.
    J Comput Aided Mol Des; 2000 Aug 16; 14(6):593-610. PubMed ID: 10921774
    [Abstract] [Full Text] [Related]

  • 6. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S, Chaubey B, Ganguly S, Harris D, Casale RA, Pandey VN.
    Nucleic Acids Res; 2005 Aug 16; 33(13):4345-56. PubMed ID: 16077030
    [Abstract] [Full Text] [Related]

  • 7. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
    Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F.
    J Mol Biol; 2004 Feb 13; 336(2):343-56. PubMed ID: 14757049
    [Abstract] [Full Text] [Related]

  • 8. Modeling of the interaction between new ethidium derivatives and TAR RNA of HIV-1.
    Terreux R, Cabrol-Bass D, Peytou V, Condom R, Guedj R.
    J Chem Inf Comput Sci; 1999 Feb 13; 39(2):413-9. PubMed ID: 10192951
    [Abstract] [Full Text] [Related]

  • 9. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
    Huq I, Tamilarasu N, Rana TM.
    Nucleic Acids Res; 1999 Feb 15; 27(4):1084-93. PubMed ID: 9927743
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS, Crothers DM.
    Biochemistry; 1999 Aug 03; 38(31):10059-69. PubMed ID: 10433713
    [Abstract] [Full Text] [Related]

  • 11. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S, Cao H, Rana TM.
    Biochemistry; 2002 May 21; 41(20):6391-7. PubMed ID: 12009901
    [Abstract] [Full Text] [Related]

  • 12. Protein orientation in the Tat-TAR complex determined by psoralen photocross-linking.
    Wang Z, Wang X, Rana TM.
    J Biol Chem; 1996 Jul 19; 271(29):16995-8. PubMed ID: 8663586
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A, Walsh AP, Rajwanshi VK, Kumar R, Wengel J, Gait MJ.
    Biochemistry; 2001 Dec 04; 40(48):14645-54. PubMed ID: 11724578
    [Abstract] [Full Text] [Related]

  • 14. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z, Huq I, Rana TM.
    Bioconjug Chem; 1999 Dec 04; 10(3):512-9. PubMed ID: 10346885
    [Abstract] [Full Text] [Related]

  • 15. Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR.
    Olsen GL, Edwards TE, Deka P, Varani G, Sigurdsson ST, Drobny GP.
    Nucleic Acids Res; 2005 Dec 04; 33(11):3447-54. PubMed ID: 15961729
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclic PNA-based compound directed against HIV-1 TAR RNA: modelling, liquid-phase synthesis and TAR binding.
    Depecker G, Patino N, Di Giorgio C, Terreux R, Cabrol-Bass D, Bailly C, Aubertin AM, Condom R.
    Org Biomol Chem; 2004 Jan 07; 2(1):74-9. PubMed ID: 14737662
    [Abstract] [Full Text] [Related]

  • 18. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z, Lind KE, James TL.
    Chem Biol; 2002 Jun 07; 9(6):707-12. PubMed ID: 12079782
    [Abstract] [Full Text] [Related]

  • 19. Dual-specificity interaction of HIV-1 TAR RNA with Tat peptide-oligonucleotide conjugates.
    Tung CH, Wang J, Leibowitz MJ, Stein S.
    Bioconjug Chem; 1995 Jun 07; 6(3):292-5. PubMed ID: 7632801
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of a new class of HIV-1 inhibitors.
    Farese-Di Giorgio A, Pairot S, Patino N, Condom R, Di Giorgio C, Aumelas A, Aubertin AM, Guedj R.
    Nucleosides Nucleotides; 1999 Feb 07; 18(2):263-75. PubMed ID: 10067276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.